We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.58%
AUM
$2.88B
AUM Growth
-$18.5M
Cap. Flow
-$108M
Cap. Flow %
-3.75%
Top 10 Hldgs %
29.44%
Holding
253
New
11
Increased
39
Reduced
127
Closed
12

Top Sells

Rank Stock Value
1
GGP
GGP Inc.
GGP
+$43.3M
2
GEL icon
Genesis Energy
GEL
+$24.6M
3
ALK icon
Alaska Air
ALK
+$19M
4
CELG
Celgene Corp
CELG
+$13.9M
5
MTDR icon
Matador Resources
MTDR
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 21.86%
2 Industrials 14.69%
3 Financials 14.54%
4 Technology 14.06%
5 Consumer Discretionary 12.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
26
Quanta Services
PWR
$93.2B
$34.3M 1.19%
+917,400
New +$32.2M
BALL icon
27
Ball Corp
BALL
$16.7B
$32.7M 1.13%
791,520
+141,795
+22% +$5.81M
WTM icon
28
White Mountains Insurance
WTM
$5.04B
$32.2M 1.12%
37,554
+250
+0.7% +$215K
DIS icon
29
Walt Disney
DIS
$185B
$32M 1.11%
324,852
+2,102
+0.7% +$216K
XOM icon
30
ExxonMobil
XOM
$667B
$30.8M 1.07%
375,110
-13,905
-4% -$1.1M
AGN
31
DELISTED
Allergan plc
AGN
$29M 1.01%
141,665
+25,870
+22% +$6.02M
AL
32
DELISTED
Air Lease Corp
AL
$28.1M 0.98%
660,326
-12,924
-2% -$516K
JNJ icon
33
Johnson & Johnson
JNJ
$671B
$28.1M 0.97%
216,162
-12,710
-6% -$1.68M
HBI
34
DELISTED
Hanesbrands
HBI
$27.3M 0.95%
1,107,194
-408,960
-27% -$9.81M
CL icon
35
Colgate-Palmolive
CL
$71.8B
$25.8M 0.9%
354,560
-6,633
-2% -$478K
AXDX
36
DELISTED
Accelerate Diagnostics
AXDX
$24.6M 0.85%
109,624
PEP icon
37
PepsiCo
PEP
$191B
$24.6M 0.85%
220,384
-5,971
-3% -$690K
FIS icon
38
Fidelity National Information Services
FIS
$21.8B
$24.5M 0.85%
262,704
-10,889
-4% -$989K
BNY
39
Bank of New York Mellon
BNY
$111B
$24.1M 0.84%
455,090
-3,199
-0.7% -$168K
PARA
40
DELISTED
Paramount Global Class B
PARA
$24M 0.83%
413,089
-18,298
-4% -$1.16M
LMT icon
41
Lockheed Martin
LMT
$123B
$22.5M 0.78%
72,534
-1,812
-2% -$541K
BHC icon
42
Bausch Health
BHC
$2.53B
$21.5M 0.75%
1,502,850
+290,050
+24% +$4.39M
LH icon
43
Labcorp
LH
$26.9B
$21.5M 0.74%
165,496
-4,115
-2% -$549K
TIF
44
DELISTED
Tiffany & Co.
TIF
$21.3M 0.74%
232,477
-17,073
-7% -$1.56M
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$20.6M 0.71%
339,263
+162,925
+92% +$9.11M
WLY icon
46
John Wiley & Sons Class A
WLY
$2.57B
$19.9M 0.69%
371,171
-11,960
-3% -$642K
GPT
47
DELISTED
Gramercy Property Trust
GPT
$19.7M 0.68%
651,039
-119,022
-15% -$3.56M
CMCSA icon
48
Comcast
CMCSA
$94.6B
$18.9M 0.65%
490,688
-10,411
-2% -$410K
AGN.PRA
49
DELISTED
Allergan plc
AGN.PRA
$18.8M 0.65%
25,503
+5,252
+26% +$4.36M
SLB icon
50
SLB Ltd
SLB
$85.2B
$18.5M 0.64%
265,014
-3,215
-1% -$213K

Similar funds

Cannell & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Cannell & Co held 253 positions worth $2.88B, down 0.64% from $2.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cannell & Co withdrew a net $108M in Q3 2017, closing 12 positions and reducing 127 holdings. Its most notable exit was Genesis Energy, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

Against the trend, Cannell & Co opened a new position in Coca-Cola Europacific Partners worth $36M.

  • Cannell & Co's largest Q3 2017 buy was Coca-Cola Europacific Partners: 864,810 shares worth $36M.
  • Cannell & Co added most to Royal Dutch Shell PLC ADS Class A in Q3 2017, an estimated $9.11M increase.
  • Cannell & Co's biggest Q3 2017 reduction was GGP Inc., cutting an estimated $43.3M.
  • Cannell & Co fully exited Genesis Energy in Q3 2017, selling an estimated $24.6M.
  • Cannell & Co's ten largest holdings make up 29% of its $2.88B portfolio in Q3 2017.
  • Cannell & Co opened 11 new positions and closed 12 in Q3 2017.
  • Cannell & Co's portfolio value fell 0.64% quarter-over-quarter to $2.88B.

Based on Cannell & Co's 13F filing for Q3 2017, filed 8 Nov 2017.